Literature DB >> 11544326

Synergistic induction of apoptosis in primary CD4(+) T cells by macrophage-tropic HIV-1 and TGF-beta1.

J Wang1, E Guan, G Roderiquez, M A Norcross.   

Abstract

Depletion of CD4(+) T lymphocytes is a central immunological characteristic of HIV-1 infection. Although the mechanism of such CD4(+) cell loss following macrophage-tropic (R5) HIV-1 infection remains unclear, interactions between viral and host cell factors are thought to play an important role in the pathogenesis of HIV-1 disease. Based on the observation that TGF-beta1 enhanced expression of HIV chemokine coreceptors, the role of this host factor in virus effects was investigated using PBLs cultured in a nonmitogen-added system in the absence or presence of TGF-beta1. Most CD4 cells in such cultures had the phenotype CD25(-)CD69(-)DR(-)Ki67(-) and were CD45RO(bright)CD45RA(dim). Cultured cells had increased expression of CCR5 and CXCR4 and supported both HIV-1 entry and completion of viral reverse transcription. Virus production by cells cultured in the presence of IL-2 was inhibited by TGF-beta1, and this inhibition was accompanied by a loss of T cells from the culture and an increase in CD4(+) T cell apoptosis. Whereas R5X4 and X4 HIV-1 infection was sufficient to induce T cell apoptosis, R5 HIV-1 failed to induce apoptosis of PBLs in the absence of TGF-beta1 despite the fact that R5 HIV-1 depletes CD4(+) T cells in vivo. Increased apoptosis with HIV and TGF-beta1 was associated with reduced levels of Bcl-2 and increased expression of apoptosis-inducing factor, caspase-3, and cleavage of BID, c-IAP-1, and X-linked inhibitor of apoptosis. These results show that TGF-beta1 promotes depletion of CD4(+) T cells after R5 HIV-1 infection by inducing apoptosis and suggest that TGF-beta1 might contribute to the pathogenesis of HIV-1 infection in vivo.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11544326     DOI: 10.4049/jimmunol.167.6.3360

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

1.  Mechanisms of apoptosis of T-cells in human tuberculosis.

Authors:  Christina S Hirsch; John L Johnson; Alphonse Okwera; Richard A Kanost; Mianda Wu; Pierre Peters; Mathew Muhumuza; Harriet Mayanja-Kizza; Roy D Mugerwa; Peter Mugyenyi; Jerrold J Ellner; Zahra Toossi
Journal:  J Clin Immunol       Date:  2005-07       Impact factor: 8.317

2.  Transforming growth factor-beta1 increases CXCR4 expression, stromal-derived factor-1alpha-stimulated signalling and human immunodeficiency virus-1 entry in human monocyte-derived macrophages.

Authors:  Shuzhen Chen; Daniel L Tuttle; Joseph T Oshier; Harm J Knot; Wolfgang J Streit; Maureen M Goodenow; Jeffrey K Harrison
Journal:  Immunology       Date:  2005-04       Impact factor: 7.397

Review 3.  Regulation of the Immune Response by TGF-β: From Conception to Autoimmunity and Infection.

Authors:  Shomyseh Sanjabi; Soyoung A Oh; Ming O Li
Journal:  Cold Spring Harb Perspect Biol       Date:  2017-06-01       Impact factor: 10.005

Review 4.  The Role of Transforming Growth Factor Beta-1 in the Progression of HIV/AIDS and Development of Non-AIDS-Defining Fibrotic Disorders.

Authors:  Annette J Theron; Ronald Anderson; Theresa M Rossouw; Helen C Steel
Journal:  Front Immunol       Date:  2017-11-02       Impact factor: 7.561

5.  Enhanced Intestinal TGF-β/SMAD-Dependent Signaling in Simian Immunodeficiency Virus Infected Rhesus Macaques.

Authors:  Nongthombam Boby; Alyssa Ransom; Barcley T Pace; Kelsey M Williams; Christopher Mabee; Arpita Das; Sudesh K Srivastav; Edith Porter; Bapi Pahar
Journal:  Cells       Date:  2021-04-04       Impact factor: 6.600

6.  Suppressive effect mediated by human adipose-derived stem cells on T cells involves the activation of JNK.

Authors:  Yinmin Wang; Xiuxia Wang; Xianyu Zhou; Zhu Zhu; Jun Yang; Fei Liu
Journal:  Int J Mol Med       Date:  2018-10-24       Impact factor: 4.101

7.  TGFβRI antagonist inhibits HIV-1 Nef-induced CC chemokine family ligand 2 (CCL2) in the brain and prevents spatial learning impairment.

Authors:  Gladys Chompre; Neysha Martinez-Orengo; Myrella Cruz; James T Porter; Richard J Noel
Journal:  J Neuroinflammation       Date:  2019-12-11       Impact factor: 8.322

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.